Evaluation of NWRD08 for HPV-16 and/or HPV-18 Related Cervical HSIL

NCT07175662 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

High-grade Squamous Intraepithelial Lesion (HSIL)

Interventions

BIOLOGICAL: NWRD08 administered by electroporation
BIOLOGICAL: Placebo administered by electroporation

Sponsor

Newish Biotech (Wuxi) Co., Ltd.